Treace Medical Concepts announced it will highlight new product innovations and present new interim data for the ALIGN3D and Mini3D Lapiplasty clinical studies at the American Orthopaedic Foot & Ankle Society, AOFAS, Annual Meeting 2024 in Vancouver, British Columbia, Canada from September 11-14, 2024. Several current and next-generation technologies will be highlighted at Treace’s booth and in surgeon training events at the AOFAS conference, including: Nanoplasty MIS 3D Osteotomy System; IntelliGuide PSI Cut Guides for Lapiplasty and Adductoplasty Procedures; Mini-Adductoplasty Guides; New SpeedPlate Innovations; and Micro-Lapiplasty Minimally Invasive System
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMCI:
- Treace Highlights New Product Innovations and Updated Clinical Study Data at the American Orthopaedic Foot & Ankle Society Annual Meeting 2024
- Treace Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference
- Treace Medical backs FY24 revenue view $201M-$211M, consensus $205.4M
- Treace Medical reports Q2 EPS (34c), consensus (29c)
- Treace to Report Second Quarter 2024 Financial Results on August 6, 2024